Motley Fool Wealth Management LLC lowered its stake in Danaher Corporation (NYSE:DHR – Free Report) by 17.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 51,445 shares of the conglomerate’s stock after selling 10,807 shares during the quarter. Motley Fool Wealth Management LLC’s holdings in Danaher were worth $11,777,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. Norges Bank acquired a new stake in Danaher in the 4th quarter valued at about $2,177,106,000. Viking Global Investors LP lifted its holdings in Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after acquiring an additional 2,455,994 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Danaher by 104.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after acquiring an additional 2,216,789 shares during the last quarter. Generation Investment Management LLP lifted its holdings in Danaher by 34.0% in the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock valued at $1,319,354,000 after acquiring an additional 1,689,020 shares during the last quarter. Finally, Capital International Investors lifted its holdings in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after acquiring an additional 1,487,768 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Price Performance
DHR stock opened at $188.38 on Wednesday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The firm has a market capitalization of $133.33 billion, a PE ratio of 36.44, a P/E/G ratio of 2.45 and a beta of 0.81. The firm has a 50-day moving average of $181.33 and a two-hundred day moving average of $205.56.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio is currently 30.95%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on DHR shares. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. TD Cowen cut their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Citigroup started coverage on shares of Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target for the company. Finally, Morgan Stanley cut their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $235.14.
Read Our Latest Stock Analysis on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
